SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Ralston S 1999 The genetics of osteoporosis. Bone 25:8586.
  • 2
    Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ 1985 Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 7:178208.
  • 3
    Benes H, Weinstein RS, Zheng W, Thaden JJ, Jilka RL, Manolagas SC, Shmookler Reis RJ 2000 Chromosomal mapping of osteopenia-associated quantitative trait loci using closely related mouse strains. J Bone Miner Res 15:626633.
  • 4
    Shimizu M, Higuchi K, Bennett B, Xia C, Tsuboyama T, Kasai S, Chiba T, Fujisawa H, Kogishi K, Kitado H, Kimoto M, Takeda N, Matsushita M, Okumura H, Serikawa T, Nakamura T, Johnson TE, Hosokawa M 1999 Identification of peak bone mass QTL in a spontaneously osteoporotic mouse strain. Mamm Genome 10:8187.
  • 5
    Niu T, Chen C, Cordell H, Yang J, Wang B, Wang Z, Fang Z, Schork N, Rosen CJ, Xu X 1999 A genome-wide scan for loci linked to forearm bone mineral density. Hum Genet 104:226233.
  • 6
    Koller DL, Econs MJ, Morin PA, Christian JC, Hui SL, Parry P, Curran ME, Rodriguez LA, Conneally PM, Joslyn G, Peacock M, Johnston CC, Foroud T 2000 Genome screen for QTLs contributing to normal variation in bone mineral density and osteoporosis. J Clin Endocrinol Metab 85:31163120.
  • 7
    Uitterlinden AG, Burger H, Quiju H, Fang Y, McGuigan FE, Grant SF, Hofman A, van Lleuwen JP, Pols HA, Ralston SH 1998 Relation of alleles of the collagen type 1α1 gene to bone density and risk of osteoporotic fractures in postmenopausal women. N Engl J Med 338:10161021.
  • 8
    Langdahl BL, Lokke E, Carstens M, Stenkjaer LL, Eriksen EF 2000 Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1-receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene. J Bone Miner Res 15:402414.
  • 9
    Raymond MH, Schutte BC, Torner JC, Burns TL, Willing MC 1999 Osteocalcin: Genetic and physical mapping of the human gene BGLAP and its potential role in postmenopausal osteoporosis. Genomics 60:210217.
  • 10
    Bertoldo F, D'Agruma L, Furlan F, Colapietro F, Lorenzi MT, Maiorano N, Iolascon A, Zelante L, Locascio V, Gasparini P 2000 Transforming growth factor-beta1 gene polymorphism, bone turnover, and bone mass in Italian postmenopausal women. J Bone Miner Res 15:634639.
  • 11
    Werner MH, Shigesada K, Ito Y 1999 Runt domains take the lead in hematopoiesis and osteogenesis. Nat Med 5:13561357.
  • 12
    Lee B, Thirunavukkarasu K, Zhou L, Pastore L, Baldini A, Hecht J, Geoffroy V, Ducy P, Karsenty G 1997 Missense mutation abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat Genet 16:307310.
  • 13
    Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson R, Gao Y, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T 1997 Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblast. Cell 89:755764.
  • 14
    Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ 1997 Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765771.
  • 15
    Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JH, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR 1997 Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89:773779.
  • 16
    Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G 1999 A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 13:10251036.
  • 17
    Sato M, Morii E, Komori T, Kawahata H, Sugimoto M, Terai K, Shimizu H, Yasui T, Ogihara H, Yasui N, Ochi T, Kitamura Y, Ito Y, Nomura S 1998 Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues. Oncogene 17:15171525.
  • 18
    Harada H, Tagashira S, Fujiwara M, Ogawa S, Katsumata T, Yamaguchi A, Komori T, Nakatsuka M 1999 Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem 274:69726978.
  • 19
    Thirunavukkarasu K, Mahajan M, McLarren KW, Stifani S, Karsenty G 1998 Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbf-beta. Mol Cell Biol 18:41974208.
  • 20
    Quack I, Vonderstrass B, Stock M, Aylsworth A, Becker A, Brueton L, Lee P, Majewski F, Mulliken J, Suri M, Zenker M, Mundlos S, Otto F 1999 Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia. Am J Hum Genet 65:12681278.
  • 21
    Pasco JA, Henry MJ, Gaudry T, Nicholson GC, Kotowicz MA 1999 Identification of incident fractures: The Geelong Osteoporosis Study. Aust N Z J Med 29:203206.
  • 22
    Henry MJ, Pasco JA, Nicholson GC, Seeman E, Kotowicz MA 2000 Prevalence of osteoporosis in Australian women: Geelong osteoporosis study. J Clin Densitom 3:261268.
  • 23
    Sanders KM, Pasco JA, Ugoni AM, Nicholson GC, Seeman E, Martin TJ, Skoric B, Panahi S, Kotowicz MA 1998 The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: The Geelong Osteoporosis Study. J Bone Miner Res 13:13371342.
  • 24
    Sanders KM, Seeman E, Ugoni AM, Pasco JA, Martin TJ, Skoric B, Nicholson GC, Kotowicz MA 1999 Age- and gender-specific rate of fractures in Australia: A population-based study. Osteoporos Int 10:240247.
  • 25
    Carter DR, Bouxsein ML, Marcus R 1992 New approaches for interpreting projected bone densitometry data. J Bone Miner Res 7:137145.
  • 26
    Audi L, Garcia-Ramirez M, Carrascosa A 1999 Genetic determinants of bone mass. Horm Res 51:105123.